Document is current
Any future updates will be listed below
-
Authors
Hoppe, Reiner https://orcid.org/0000-0003-2213-9612
Winter, Stefan
Lo, Wing-Yee
Michailidou, Kyriaki https://orcid.org/0000-0001-7065-1237
Bolla, Manjeet K. https://orcid.org/0000-0002-4351-9326
Keeman, Renske https://orcid.org/0000-0002-5452-9933
Wang, Qin
Dennis, Joe https://orcid.org/0000-0003-4591-1214
Lush, Michael
Kalari, Krishna R.
Goetz, Matthew P. https://orcid.org/0000-0002-4383-270X
Wang, Liewei https://orcid.org/0000-0003-3818-8531
Cairns, Junmei
Weinshilboum, Richard https://orcid.org/0000-0002-4911-7985
Shepherd, Lois
Chen, Bingshu E. https://orcid.org/0000-0001-6139-0696
Häberle, Lothar
Ruebner, Matthias
Beckmann, Matthias W.
He, Wei
Larson, Nicole L.
Armasu, Sebastian M.
Schroth, Werner
Chowbay, Balram
Khor, Chiea Chuen https://orcid.org/0000-0002-1128-4729
Abubakar, Mustapha https://orcid.org/0000-0003-3728-6535
Antoniou, Antonis C.
Brüning, Thomas
Castelao, Jose E.
Chang-Claude, Jenny https://orcid.org/0000-0001-8919-1971
NBCS Collaborators,
Dörk, Thilo https://orcid.org/0000-0002-9458-0282
Eccles, Diana M. https://orcid.org/0000-0002-9935-3169
Figueroa, Jonine D. https://orcid.org/0000-0002-5100-623X
Gago-Dominguez, Manuela
García-Sáenz, José A. https://orcid.org/0000-0001-6880-0301
Gündert, Melanie
Hack, Carolin C.
Hamann, Ute
Han, Sileny
Hooning, Maartje J.
Huebner, Hanna https://orcid.org/0000-0001-6889-1493
ABCTB Investigators,
John, Esther M.
Ko, Yon-Dschun
Kristensen, Vessela N. https://orcid.org/0000-0001-5012-7438
Linn, Sabine https://orcid.org/0000-0001-5541-0347
Margolin, Sara
Mavroudis, Dimitrios
Nevanlinna, Heli https://orcid.org/0000-0002-0916-2976
Neven, Patrick
Obi, Nadia
Park-Simon, Tjoung-Won
Pylkäs, Katri
Rashid, Muhammad U. https://orcid.org/0000-0002-7684-3122
Romero, Atocha https://orcid.org/0000-0002-1634-7397
Saloustros, Emmanouil https://orcid.org/0000-0002-0485-0120
Sawyer, Elinor J. https://orcid.org/0000-0001-8285-4111
Tapper, William J.
Tomlinson, Ian
Wendt, Camilla
Winqvist, Robert https://orcid.org/0000-0003-0932-9104
Dunning, Alison M. https://orcid.org/0000-0001-6651-7166
Simard, Jacques https://orcid.org/0000-0001-6906-3390
Hall, Per https://orcid.org/0000-0002-5640-9126
Pharoah, Paul D. P. https://orcid.org/0000-0001-8494-732X
Schwab, Matthias https://orcid.org/0000-0002-9984-075X
Couch, Fergus J.
Czene, Kamila
Fasching, Peter A. https://orcid.org/0000-0003-4885-8471
Easton, Douglas F. https://orcid.org/0000-0003-2444-3247
Schmidt, Marjanka K. https://orcid.org/0000-0002-2228-429X
Ingle, James N. https://orcid.org/0000-0003-1257-7731
Brauch, Hiltrud https://orcid.org/0000-0001-7531-2736
- License Information
-
More Information
Article History
Received: 24 July 2024
Accepted: 4 February 2025
First Online: 19 February 2025
Competing interests
: Peter A. Fasching reports personal fees from Novartis, Pfizer, Daiichi-Sankyo, AstraZeneca, Eisai, Merck Sharp & Dohme, Lilly, Pierre Fabre, SeaGen, Roche, Hexal, Agendia, and Gilead and grants from Biontech and Cepheid. Carolin C. Hack received Honoraria from AstraZeneca, Daiichi Sankyo, Eisai, Novartis, Pfizer, Roche, Gilead and MSD as well as support for attending meetings from Daiichi Sankyo. Matthias Schwab received funding from Agena Bioscience GmbH, HepaRegenix GmbH, Robert Bosch GmbH, and CORAT Therapeutics GmbH, as well as honoraria for oral presentations at academically organized congresses and meetings; he received payment for expert testimony from the Research Impact Fund Committee (RIF), Research Grant Council (RCG), Hong Kong, and from the German Federal Ministry of Education and Research (BMBF); he is (section-) editor for Pharmacogenetics and Genomics, Drug Research, and Genome Medicine. Diana M. Eccles has received research support from AstraZeneca. Matthew P. Goetz reports consulting fees to Mayo Clinic from ARC Therapeutics, AstraZeneca, Biotheranostics, Blueprint Medicines, Lilly, Novartis, Rna Diagnostics, Sanofi Genzyme, Seattle Genetics, Sermonix, Engage Health Media, Laekna and TerSera Therapeutics/Ampity Health; grant funding to Mayo Clinic from Lilly, Pfizer, Sermonix, Loxo, AstraZeneca and ATOSSA Therapeutics; personal fees for CME activities from Research to Practice, Clinical Education Alliance, Medscape, and MJH Life Sciences; personal fees serving as a panelist for a panel discussion from Total Health Conferencing and personal fees for serving as a moderator for Curio Science; and travel support from Lilly. All other authors report no conflict of interest.
